Skip to Content Skip to Footer

Dr. Betageri is well-recognized for his research in the development and evaluation of liposomal and proliposomal drug delivery systems and his research has led to numerous articles, book chapters as well as a book. Dr. Betageri is considered one of the top researchers and experts in this particular area of drug delivery. Besides his research papers, he has over 130 research presentations and abstracts with most presented at the top national and international pharmaceutical meetings. Due to his recognition as an expert in novel and traditional dosage forms, he has had opportunities to obtain funding from both small and large pharmaceutical companies. Dr. Betageri has done excellent work for these companies and they continue to seek his advice and assistance. Further evidence of his stature is the large number of invited lectures that he has presented at various pharmaceutical companies, national and international symposiums in several countries including, China, Germany, India, Japan, Poland, and US. He has an outstanding number of publications (70+) which have appeared in some of the best pharmaceutical research journals.

Formulation Capabilities:  

Formulation and Development of Conventional and Novel Dosage forms and Drug Delivery Systems:

I. Conventional:

Tablets
Capsules
Solutions
Suspensions
Emulsions
Ointments
Suppositories
Injectables (including lyophilization)

II. Novel:
Liposomes
Proliposomes
Microspheres
Nanospheres

  • Recent Publications
    1. S. Chopra, N. Venkatesan and G.V. Betageri. Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs. Int. J. Pharm. 446: 136-144, 2013.
    2. S. Chopra, N. Venkatesan and G.V. Betageri. Liposomes as nanocarriers for anti-HIV therapy. Drug Delivery and Translational Research. (Accepted for publication) 2013.
    3. K. Muppidi, A. S. Pumerantz, G. Betageri, J. Wang.  Development and validation of a rapid high-performance liquid chromatography method with UV detection for the determination of vancomycin in mouse plasma. Chrom. Sep. Tech. (Accepted for publication) 2013.
    4. K. Muppidi, A. Pumerantz, J. Wang, and G. V. Betageri. Development and stability studies of novel vancomycin formulations. ISRN Pharmaceutics. 1-8, 2012.
    5. V. G. Kadajji and G. V. Betageri. Water soluble polymers for pharmaceutical applications. Polymer Sci. 3: 1972-2009, 2011.
    6. V.G. Kadajji, N. Venkatesan and G. V. Betageri. Approaches for dissolution testing of novel drug delivery systems. Pharm. Rev. 38-42, 2011.
    7. K. Muppidi, J. Wang, G. V. Betageri and A. S. Pumerantz. PEGylated Liposome Encapsulation Increases the Lung Tissue Concentration of Vancomycin. Antimicrb. Agents Chemother. 55: 4537-4542, 2011.
    8. A. Pumerantz, K. Muppidi, S. Agnihotri, C. Guerra, V. Venketaraman, J. Wang, G. V. BetageriLiposomal vancomycin: Preparation and intracellular killing of MRSA. Int. J. Antimicrb. Agents. 37: 140-144, 2011.
    9. S. A. Agnihotri, K.S. Soppimath and G. V. Betageri. Controlled release application of multilamellar vesicles: A novel drug delivery approach. Drug Del. 17: 92-101, 2010.
    10. D. Deshmukh, R. Nagilla, W. R. Ravis and G.V. Betageri. Effect of dodecylmaltoside (DDM) on uptake of BCS III compounds, tiludronate and cromolyn, in Caco-2 cells and rat intestinal model. Drug Del. 17: 145-151, 2010.
  • Patents
    Country Patent  No. Title Issue Date Expiration Date
    US 6,759,058 ENTERIC-COATED PROLIPOSOMAL FORMULATIONS FOR POORLY WATER SOLUBLE DRUGS 7/6/2004 08/16/2021
    US 6,849,269 PROLIPOSOMAL DRUG DELIVERY SYSTEM 2/1/2005 08/16/2021
    Japan 440515       (App 2002-

    582880)

    PROLIPOSOMAL DRUG DELIVERY SYSTEM 11/13/2009 4/24/2022
    India 233635 PROLIPOSOMAL DRUG DELIVERY SYSTEM 4/24/2009 4/24/2022
    Australia AU2002256353 PROLIPOSOMAL DRUG DELIVERY SYSTEM 4/24/2002 4/24/2022
  • View biographical information

    Portrait of

    Guru Betageri, PhD

    Professor, Pharmaceutical Sciences; Associate Provost, Graduate Studies

    gbetageri@westernu.edu